tesevatinib

tesevatinib · Kadmon Corporation, LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for tesevatinib, covering 2021-09-22 to 2023-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD [Phase 2]